Downregulation of CXADR appears to sensitize breast cancer cells to TGFβ‐induced EMT, and its low expression correlates with poor prognosis in luminal A breast cancers (Nilchian et al., 2019). The gene discussed is CXADR; the disease is breast carcinoma.